Literature DB >> 13000148

Properties of scarlet fever toxin of the NY5 strain.

A H STOCK, E VERNEY.   

Abstract

Entities:  

Keywords:  COMPLEMENT; SCARLET FEVER

Mesh：

Substances：

Year:  1952        PMID： 13000148

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Pyrogenic specificity of streptococcal exotoxins, staphylococcal enterotoxin, and gram-negative endotoxin.

Authors:  K W Brunson; D W Watson
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

2.  Limulus amebocyte lysate reaction with streptococcal pyrogenic exotoxin.

Authors:  K W Brunson; D W Watson
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

3.  The use of precipitin analysis in agar for the study of human streptococcal infections. III. The purification of some of the antigens detected by these methods.

Authors:  S P HALBERT
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

4.  A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.

Authors:  Y B Kim; D W Watson
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

5.  The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics.

Authors:  S P HALBERT; L SWICK; C SONN
Journal:  J Exp Med       Date:  1955-05-01       Impact factor: 14.307

6.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

7.  The use of precipitin analysis in agar for the study of human streptococcal infections. IV. Further observations on the purification of group A extracellular antigens.

Authors:  S P HALBERT; T AUERBACH
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.